TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata
November 02, 2015 07:00 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Nov. 2, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a Phase...
TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update
August 05, 2015 16:01 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Aug. 5, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
TetraLogic Provides Update on Hepatitis B Clinical Program
July 20, 2015 16:02 ET
|
TetraLogic Pharmaceuticals
MALVERN, Pa., July 20, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) a clinical-stage biopharmaceutical company focuses on discovering and developing novel small...
Hepatitis B Patients Benefit from New Co-Payment Assistance Fund
January 08, 2015 09:38 ET
|
Patient Advocate Foundation
HAMPTON, Va., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Patient Advocate Foundation (PAF) is pleased to announce the addition of a new assistance fund to their Co-Pay Relief program dedicated to assisting...
OnCore Biopharma Announces Exclusive HBV Research Collaboration With the Baruch S. Blumberg Institute
November 19, 2014 07:00 ET
|
OnCore Biopharma, Inc.
DOYLESTOWN, Pa., Nov. 19, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biopharmaceutical company focused on the research, development and commercialization of oral...
OnCore Biopharma Agrees to Acquire Enantigen Therapeutics
October 01, 2014 02:00 ET
|
OnCore Biopharma, Inc.
DOYLESTOWN, Pa., Oct. 1, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biotechnology company focused on the research, development and commercialization of oral...